Combating Alzheimer's Disease With Multifunctional Molecules Designed for Metal Passivation-Reference-Cited by-同舟云学术

Combating Alzheimer's Disease With Multifunctional Molecules Designed for Metal Passivation

Published:2007-02-26 Issue:10 Volume:46 Page:1716-1718
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Schugar Harvey,Green David E.,Bowen Meryn L.,Scott Lauren E.,Storr Tim,Böhmerle Karin,Thomas Fancy,Allen David D.,Lockman Paul R.,Merkel Michael,Thompson Katherine H.,Orvig Chris

Publisher

Wiley

Subject

General Chemistry,Catalysis

Reference28 articles.

1. The metallobiology of Alzheimer's disease

2. Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)

3. Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease

4. Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

5. Intramuscular desferrioxamine in patients with Alzheimer's disease

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Biometals in Alzheimer’s Disease with Metal Chelating Agents Including Coumarin Derivatives;CNS Drugs;2024-06-03

2. Targeting misfolding and aggregation of the amyloid-β peptide and mutant p53 protein using multifunctional molecules;Chemical Communications;2024

3. Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer’s Disease;Neurotoxicity Research;2023-01-27

4. Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer’s Diseases: Emerging Paradigms and Strategies;International Journal of Molecular Sciences;2022-05-29

5. Synthesis, physicochemical characterization and neuroprotective evaluation of novel 1-hydroxypyrazin-2(1H)-one iron chelators in an in vitro cell model of Parkinson's disease;Dalton Transactions;2022